NIH-funded research R01 grant

Pennsylvania asthma-COPD syndromic surveillance for cleaner air and healthier kids

Official title: SCH: Pennsylvania Asthma-COPD Syndromic Surveillance (PASS)

Funded at Lehigh University · NIH-11362713 · Data updated 2026-11-12

A Pennsylvanian health project is building a real-time warning system to help doctors and families spot spikes in asthma and COPD risks related to air pollution and smoke.

More Asthma research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLehigh University
NIH-funded
Lab location1 site (Bethlehem, United States)
Project startJuly 6, 2024
Project endApril 30, 2028
Funding year2026
Award (this year)$241,796
NIH project number5R01ES037163-03
Project IDNIH-11362713 on NIH RePORTER

Who could benefit from this research

Could help

Children aged 0-11 with asthma or risk factors for respiratory conditions, and local clinics serving these populations.

Less likely to help

Patients not affected by asthma or COPD or living in areas without the proposed alert system implementation.

What this research studies

This project from Lehigh University aims to create an early-warning system that uses geospatial maps and prediction algorithms to alert communities and clinicians about rising risk of respiratory problems tied to air pollution and tobacco smoke. It focuses on children in the 0-11 age range and aims to separate environmental risks from other factors like housing and economics. The work envisions practical tools for patients and clinics to reduce unnecessary hospital visits and improve care planning in high-risk areas like Allentown and the Lehigh Valley.

Why it matters

Potential benefit: If successful, it could help families and clinicians anticipate dangerous air-quality days and better protect children with asthma or COPD.

How similar studies have gone: Previous air-pollution health studies show promise for predictive models, but this project adapts them to a targeted Pennsylvania setting with a real-time warning interface.

Where this research is happening

  • Lehigh University
    Bethlehem, United States
    Active

Researchers

  • Principal investigator: Choi, Hyunok — Lehigh University
  • Study coordinator: Choi, Hyunok

Related research

Other NIH-funded projects on the same topics.

  • How climate change affects respiratory health in asthma and COPD patients

    This study, led by Dr. Nicholas Nassikas, is looking at how changes in weather, like temperature and rainfall, affect the breathing health of people with asthma and COPD, especially in Black and Latinx communities, to find ways to help them feel better as our climate changes.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11061756

  • Understanding the link between asthma and COPD using advanced data analysis

    This study is looking at how asthma and COPD are related, especially how things like being exposed to smoke before birth can affect lung health throughout life, and it's for anyone interested in understanding the biological factors that might influence these breathing conditions.

    NIH research Brigham and Women's Hospital · Boston, United States · NIH-10870139

  • Investigating how genetics and ancestry affect asthma and COPD treatment responses

    This study is looking at how your unique genes and background might affect how well asthma and COPD medications work for you, and it invites patients to share their genetic information to help find out more about this connection.

    NIH research Mayo Clinic Arizona · Scottsdale, United States · NIH-10620284

  • Improving access to specialist care for patients with COPD and asthma

    This study is testing a new way to help people with COPD and asthma get better care by connecting them with lung specialists through health coaches, so they can receive helpful advice without having to go to the hospital.

    NIH research University of California, San Francisco · San Francisco, United States · NIH-10451757

  • Omalizumab for COPD patients with allergen sensitization and exposure

    A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11624859

  • GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults

    Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.

    NIH research Vanderbilt University Medical Center · Nashville, United States · NIH-11616517

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.